Lucid Diagnostics EBITDA 2021-2025 | LUCD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Lucid Diagnostics ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Lucid Diagnostics ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$180.3B
Intuitive Surgical (ISRG)	$171.4B
IDEXX Laboratories (IDXX)	$52.2B
Edwards Lifesciences (EW)	$45.2B
Alcon (ALC)	$42.4B
IQVIA Holdings (IQV)	$31.6B
DexCom (DXCM)	$31.4B
Mettler-Toledo (MTD)	$26.6B
STERIS (STE)	$24B
Waters (WAT)	$17B
SONOVA HOLDING (SONVY)	$16.7B
Hologic (HOLX)	$15.1B
Penumbra (PEN)	$9.7B
Sysmex ADR (SSMXY)	$8.8B
Globus Medical (GMED)	$8.4B
Masimo (MASI)	$8.2B
Teleflex (TFX)	$5.3B
Glaukos (GKOS)	$5.1B
TransMedics (TMDX)	$4.5B
Integer Holdings (ITGR)	$3.8B
LivaNova (LIVN)	$2.8B
Alphatec Holdings (ATEC)	$2.3B
Veracyte (VCYT)	$2.3B
PROCEPT BioRobotics (PRCT)	$2.1B
Nihon Kohden (NHNKY)	$2.1B
Artivion (AORT)	$2.1B
Elekta AB (EKTAY)	$1.9B
Paragon 28 (FNA)	$1.1B
Integra LifeSciences Holdings (IART)	$1.1B
OPKO Health (OPK)	$1B